Ngs 2024. Esmo updates the recommendations for the use of tumour ngs in patients with advanced cancers in routine practice. 2024 is a key year for globally considering ngs implementation with the recent publication of the revised ichq5a (r2) guideline and the upcoming draft chapter on.
Join 700+ leaders, experts and researchers at our flagship nextgen omics 2024, featuring the 16th annual ngs & clinical diagnostics congress, 12th annual single cell & spatial analysis. The impact of our garden at rhs chelsea 2024.